**Abstract**

**Objectives:** Few studies have investigated antidepressant(AD) prescriptions for patients with schizophrenia. The aim of this study was to identify the sociodemographic and clinical correlates and prescription patterns of ADs among schizophrenia patients.

**Methods:** Schizophrenia patients were recruited and interviewed using standardized assessment instruments. Differences in demographic and clinical characteristics including current psychiatric symptoms, and concomitant psychotropic medications between patients with and without ADs were analyzed. Brief Psychiatric Rating Scale (BPRS) was used to evaluate current psychiatric symptoms.

**Result:** Among 297 patients, 78 (27%) patients received an AD prescription. The most commonly used ADs were Escitalopram(30.8%), Sertraline (25.6%), and Fluoxetine(10.3%). As for the combined prescription rate of psychotropic medications, there was only significantly greater rates of benzodiazepine prescription for AD user compared to AD nonuser(p=0.005).

With regard to sociodemographic characteristics, there was no significant difference between two groups. As for clinical aspects, we found that anxiety (p=0.007) and depressive mood (p=0.014) scores of patients taking AD were significantly higher than patients not taking AD in respect of BPRS. On the contrary, Excitement (p\<0.001) and Grandiosity (p=0.003) scores were significantly lower among AD user compared to AD nonuser.

**Conclusion:** This study showed that the most commonly used AD is SSRI with the prevalence of 27% among schizophrenia patients. In addition, current AD use for schizophrenia compared to nonuse is likely to be related with anxiety and depressive symptoms regardless of positive and negative symptoms currently. Further evaluation of anxiety and depressive symptoms and management of those symptoms may improve quality of life and drug compliance for patients with schizophrenia.
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